NICE (UK) negative for Imdylltra (tarlatamab) for extensive-stage small-cell lung cancer after 2 or more treatments – Amgen
NICE (UK): Tarlatamab should not be used to treat extensive-stage small-cell lung cancer in adults whose cancer has progressed after 2 or more lines of treatment, including platinum-based… read more.